Bibliography (9):

1. Exploiting evolutionary steering to induce collateral drug sensitivity in cancer

2. Controlling the speed and trajectory of evolution with counterdiabatic driving

3. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

4. Cancer across the tree of life: cooperation and cheating in multicellularity

5. Evolutionary models predict potential mechanisms of escape from mutational meltdown

6. Engineering complex communities by directed evolution

7. Somatic evolution and global expansion of an ancient transmissible cancer lineage

8. Wikipedia Bibliography:

   1. https://en.wikipedia.org/wiki/Tumor_evolution

      https://en.wikipedia.org/wiki/Tumor_evolution

   2. https://en.wikipedia.org/wiki/Tyrosine_kinase_inhibitor

      https://en.wikipedia.org/wiki/Tyrosine_kinase_inhibitor